WHO backs wider use of weight-loss medicines, calling obesity a chronic disease
The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and offers conditional recommendations on...
medicines
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO)...
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
NEW YORK and TRUMBULL, Conn., April 30, 2025 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy...
The Strategic Advisory Group on Increasing Regional Innovation and Production Capacities for Medicines and other Health Technologies held its first meeting – PAHO/WHO
Washington, D.C., Dec. 13, 2024 (PAHO) - PAHO's Strategic Advisory Group (SAG) on Increasing Regional Innovation and Production Capacities for...
WHO issues warning on falsified medicines used for diabetes treatment and weight loss
The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used...
